Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Stomach Cancer Clinical Trials

100 recruiting trials for Stomach Cancer. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
3
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT06715839

Target-specific immunoPET Imaging of Digestive System Carcinoma

The aim of this study is to establish and optimize the target-specific PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of...

Sponsor: RenJi HospitalEnrolling: 4001 location
RECRUITINGNCT07359586

Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia

This study retrospectively analyzed patients who underwent tracheal intubation under general anesthesia at the First Affiliated Hospital of Zhejiang University School of Medicine...

Sponsor: Zhejiang UniversityEnrolling: 12002 locations
RECRUITINGNCT05291728

Screening for Early Gastric Cancer in Shaanxi Province

This study collect the relevant data of local residents over 20 years old in 11 regions of Shaanxi Province, The basic information of the subjects was collected by filling in the...

Sponsor: Second Affiliated Hospital of Xi'an Jiaotong UniversityEnrolling: 125000001 location
RECRUITINGNCT05638269

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

The human gut microbiome has been associated with many health factors but variability between studies limits the exploration of effects between them. This study aims to...

Sponsor: Zhujiang HospitalEnrolling: 1200020 locations
RECRUITINGNCT06346080

Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment

The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question...

Sponsor: KU LeuvenEnrolling: 22001 location
RECRUITINGNCT05347524

Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study

This study is a prospective, multi-omics, observational study aimed at detecting peritoneal metastasis of gastric cancer by combined assays for methylation of cell-free DNA...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 3841 location
RECRUITINGPhase 2NCT06341595

Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM

This trial is a prospective, single arm, single center, phase II clinical study aimed at subjects with advanced gastric cancer and para aortic lymph node metastasis, exploring the...

Sponsor: The First Affiliated Hospital with Nanjing Medical UniversityEnrolling: 401 location
RECRUITINGNCT06102759

Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1...

This is a prospective, single-center, open, single-arm clinical study to observe and evaluate the efficacy and safety of Fruquintinib and Adebrelimab combined with...

Sponsor: Tianjin Medical University Cancer Institute and HospitalEnrolling: 301 location
RECRUITINGPhase 1 / Phase 2NCT06710756

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Phase I/IIa image-guided, alpha-particle therapy study of \[203Pb\]Pb-PSV359 and \[212Pb\]Pb-PSV359 in patients with solid tumors that are known to be Fibroblast Activation...

Sponsor: Perspective TherapeuticsEnrolling: 1123 locations
RECRUITINGNCT06923449

Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance

The goal of this observational, no-profit, spontaneous, retrospective, monocentric study is to compare surgical and oncologic outcomes in patients affected by gastric cancer...

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSEnrolling: 2501 location
RECRUITINGNCT04943484

ICG (Indocyanine Green) Imaging Fluorescence Technology in Surgical Treatment of Advanced Gastric Cancer

The iGreenGO Study aims to investigate whether the intraoperative application of NIR/ICG technology is associated with a change in the surgical conduct (CSC) during...

Sponsor: Niguarda HospitalEnrolling: 3601 location
RECRUITINGPhase 1 / Phase 2NCT05482893

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced...

This is a first-in-human, Phase 1/2, open-label, dose escalation and dose expansion and combination study designed to evaluate the safety, tolerability, pharmacokinetics,...

Sponsor: Phanes TherapeuticsEnrolling: 25811 locations
RECRUITINGPhase 1 / Phase 2NCT05439993

Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma

Purpose of this study is to define the maximal tolerated dose (MTD) and recommended phase 2 dose (RP2D) of paclitaxel and tepotinib combination therapy in patients with advanced...

Sponsor: Hallym University Medical CenterEnrolling: 421 location
RECRUITINGPhase 2NCT07315854

Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic...

The goal of this Phase II clinical trial is to evaluate the efficacy and safety of Iparomlimab and Tuvonralimab (QL1706) combined with SOX chemotherapy (S-1 plus Oxaliplatin) in...

Sponsor: Beijing Friendship HospitalEnrolling: 321 location
RECRUITINGNCT05854368

Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer

The goal of this study is to characterize and validate a signature of circulating biomarkers in plasma, associated with the presence of gastric preneoplasia in patients with...

Sponsor: Institut PasteurEnrolling: 25008 locations
RECRUITINGPhase 2NCT06468280

Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in...

ROSETTE trial is an open-label, randomized phase II study designed to investigate treatment strategies for patients with limited metastatic gastric or gastroesophageal...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 842 locations
RECRUITINGNCT05205343

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal...

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

Sponsor: M.D. Anderson Cancer CenterEnrolling: 204 locations
RECRUITINGPhase 2 / Phase 3NCT05699655

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann...

To evaluate the clinical efficacy and safety of Tislelizumab combined with apatinib mesylate, oxaliplatin plus S1 Vs oxaliplatin plus S1.

Sponsor: Fujian Cancer HospitalEnrolling: 1301 location
RECRUITINGPhase 1NCT06830031

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

This study is to investigate the safety and tolerability of C402-CD19-CAR treatment in subjects with relapsed or refractory large B-cell lymphoma and further determine the...

Sponsor: Shanghai Exuma Biotechnology Ltd.Enrolling: 181 location
RECRUITINGNCT05180864

Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer

Curative therapy for gastric cancer usually consists of perioperative chemotherapy and a radical (R0) gastrectomy. A radical resection includes a modified D2 lymphadenectomy, and,...

Sponsor: Amsterdam UMCEnrolling: 65416 locations
RECRUITINGNCT07295236

Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak

The goal of this observational study is to assess the impact of endoscopic vacuum therapy in patients who underwent total gastrectomy due to gastric cancer and developed...

Sponsor: Ukrainian Society of Clinical OncologyEnrolling: 1001 location
RECRUITINGPhase 2NCT06405113

FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer

the investigators plan to initiate a prospective, multicenter, randomized, double-blind, placebo-controlled phase II study, recruiting 198 patients with advanced...

Sponsor: Changzhou No.2 People's HospitalEnrolling: 1981 location
RECRUITINGNCT06405009

Prediction Model of Occult Omental Metastasis in Patients With Gastric Cancer

A complete omentectomy is typically recommended during radical total gastrectomy for gastric cancer, though its impact on survival remains unclear. This study aimed to assess the...

Sponsor: Northern Jiangsu People's HospitalEnrolling: 4501 location
RECRUITINGNCT06155318

68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours

Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are a heterogeneous group of neoplasms that arise from the endocrine cells of the gastroenteropancreatic tract. The...

Sponsor: IRCCS San RaffaeleEnrolling: 3001 location
RECRUITINGNCT03385018

Trial for Application of Laparoscopic Total Gastrectomy With Lymph Node Dissection for Gastric Cancer (KLASS-06)

Although Laparoscopic gastrectomy for both early and locally advanced gastric cancer has gained popularity, the use of laparoscopic total gastrectomy for proximal advanced gastric...

Sponsor: Yonsei UniversityEnrolling: 7721 location
RECRUITINGPhase 2NCT06155383

Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.

The purpose of this study is to evaluate the efficacy and safety of perioperative Disitamab Vedotin plus Toripalimab and XELOX versus Disitamab Vedotin plus Toripalimab versus...

Sponsor: RemeGen Co., Ltd.Enrolling: 9011 locations
RECRUITINGNCT07405931

Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program...

This is a multicenter randomized controlled clinical trial designed to evaluate the clinical efficacy and cost-effectiveness of a digital health platform that integrates a symptom...

Sponsor: Ulsan University HospitalEnrolling: 4145 locations
RECRUITINGPhase 2NCT04550494

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

This phase II trial studies if talazoparib works in patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the...

Sponsor: National Cancer Institute (NCI)Enrolling: 364 locations
RECRUITINGPhase 1NCT06781983

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

This is a first-in-human, open-label, multicenter, Phase 1 study to evaluate the safety, tolerability and preliminary efficacy of IPH4502 and to determine the recommended Phase 2...

Sponsor: Innate PharmaEnrolling: 1457 locations
RECRUITINGPhase 4NCT07068607

Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori...

This study aims to evaluate the efficacy of vonoprazan combined with different antibiotics in dual therapy for Helicobacter pylori eradication treatment. Newly infected patients...

Sponsor: Yongquan ShiEnrolling: 4001 location
RECRUITINGPhase 1NCT06657144

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced...

The main purpose of this study is to evaluate the safety and preliminary efficacy of CHS-114 in combination with toripalimab and/or other standard of care (SOC) compound(s) in...

Sponsor: Coherus Oncology, Inc.Enrolling: 15420 locations
RECRUITINGEarly Phase 1NCT05041153

Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma

This early phase I trial studies the effect of pembrolizumab and lenvatinib in treating patients with gastroesophageal adenocarcinoma that has spread to other places in the body...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 151 location
RECRUITINGNCT06232395

Early Detection and Post-operative Monitoring of Gastric Cancer

This study is to determine the performance of non-invasive new multi-target biomarkers in the early detection and post-operative monitoring of gastric cancer.

Sponsor: Suzhou Huhu Health & Technology Inc.Enrolling: 11972 locations
RECRUITINGPhase 1 / Phase 2NCT06742411

XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC

This study investigates the efficacy and safety of XELOX chemotherapy combined with sintilimab and hyperbaric oxygen therapy (HBOT) as a first-line treatment for patients with...

Sponsor: West China HospitalEnrolling: 572 locations
RECRUITINGPhase 2NCT07294664

PD1/TGFβ In Combination With EZH2 And Chemotherapy For First - Line Treatment Of Gastric Cancer

Immunotherapy combined with chemotherapy has become the standard first-line treatment regimen for gastric cancer. However, a subset of patients still fail to benefit or derive...

Sponsor: The First Affiliated Hospital of Zhengzhou UniversityEnrolling: 361 location
RECRUITINGNCT06356467

Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) represent the most common NeuroEndocrin Neoplasms (NEN) site, comprising 55-70% of all NENs, and they are extremely...

Sponsor: IRCCS San RaffaeleEnrolling: 4501 location
RECRUITINGPhase 2NCT06947291

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced...

The trial consists of Stage 1 (including dose escalation and dose expansion) and Stage 2 (proof-of-concept study). Among them, Stage 2 adopts a randomized, controlled, open-label,...

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Enrolling: 3501 location
RECRUITINGPhase 2NCT07259226

Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers

International study that will evaluate the association of prespecified biomarkers with resistance to Antibody-drug conjugates (ADCs), a type of targeted cancer treatment currently...

Sponsor: UNICANCEREnrolling: 4001 location
RECRUITINGPhase 1 / Phase 2NCT06380816

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

This clinical trial is looking at UCB4594. This is the first time the drug is being tested in humans. UCB4594 is a type of drug called a monoclonal antibody. It has been designed...

Sponsor: Cancer Research UKEnrolling: 1672 locations
RECRUITINGNCT03716089

Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and...

Participants with gastrointestinal stromal tumors(GIST) were divided into favorable and unfavorable sites according to the anatomical site of the tumor, and this study aims to...

Sponsor: Fujian Medical UniversityEnrolling: 2501 location
RECRUITINGPhase 3NCT07217704

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

This is a multi-site, open-label, non-randomized, single dose study to assess the clinical utility of \[¹⁸F\]FAPI-74 PET/CT in the detection of metastatic disease in individuals...

Sponsor: SOFIEEnrolling: 20010 locations
RECRUITINGNCT06915389

Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients

This study comprehensively examines metabolic and lipidomic dynamics in gastric cancer patients initiating PD-1/PD-L1 inhibitor therapy, employing a longitudinal design with pre-...

Sponsor: Qinghai Red Cross HospitalEnrolling: 1001 location
RECRUITINGPhase 1NCT05172310

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Cancers of the pancreas, bile ducts, stomach and ovaries are dismal diseases with most patients being diagnosed in advanced stages leading to a bad prognosis. These cancers can be...

Sponsor: Karolinska University HospitalEnrolling: 4101 location
RECRUITINGNCT07139418

The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With...

This study aims to examine the predictive value of metastatic gastric mesenteries, which contains metastatic lymph node, in 6 gastric mesenteries; and importantly, to further...

Sponsor: Jichao QinEnrolling: 4001 location
RECRUITINGNCT06881043

The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer

Gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer-related deaths. Surgical resection is the primary treatment, with laparoscopic-assisted...

Sponsor: The First Hospital of Jilin UniversityEnrolling: 3001 location
RECRUITINGNCT02491840

Biomoleculars Markers of Sensitivity to Pre- and Post-operative Chemotherapy of Gastric and Cardia Adenocarcinomas: a...

Some subtypes of gastric and cardia tumors such as adenocarcinoma or gastric linitis with disseminated cells respond poorly to the pre-operative chemotherapy, and some of them do...

Sponsor: University Hospital, Strasbourg, FranceEnrolling: 801 location
RECRUITINGNCT07183150

The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer

The main purpose of this study is to evaluate the reasonable range of No.4sb lymph node dissection of locally advanced distal gastric cancer.

Sponsor: Tianjin Medical University Cancer Institute and HospitalEnrolling: 4001 location
RECRUITINGPhase 2NCT05969860

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where it first started to...

Sponsor: Mayo ClinicEnrolling: 2202 locations
RECRUITINGPhase 2NCT07309185

Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy

This study employs a randomized, controlled, exploratory clinical trial design, with a planned enrollment of 66 patients who have previously failed systemic chemotherapy for...

Sponsor: Shandong Tumor HospitalEnrolling: 661 location
RECRUITINGNCT07411118

RCT of EFTR Versus STER for GIST Treatment

Endoscopic resection has been increasing utilized as the treatment for small size gastrointestinal stromal tumors (GIST), of which the best resection method has not been...

Sponsor: Chinese University of Hong KongEnrolling: 1364 locations

Showing 50 of 100 trials.Search all Stomach Cancer trials